Jordana Joy, Associate Editor

Catch up on what happened in optometry during the week of January 20-January 24.

The IOLs are equipped with a non-diffractive spiral optic, which allows for a full range of vision with minimized dysphotopsia and 0% loss of transmitted light.

Ocular Services On Demand (OSOD) has operated for over 30 years in ophthalmic preclinical drug development.

The 3-year, $4.8 million award comes from the NIH Venture Program Oculomics Initiatives.

Preclinical studies evaluating NPI-001 have found that it boosts the endogenous antioxidant glutathione, which stops chemically aggressive oxygen molecules from further damaging retinal cells, according to Nacuity Pharmaceuticals.

Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.

Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.

The Vision Council CEO Ashley Mills detailed what's new and trendy at this year's show during a webinar last week.

The trial met its primary endpoint with statistical significance for the 150mg BID dose, with a proptosis responder rate of 52% (p=0.01).

RayTrace has been utilized globally by surgeons since 2008.

Catch up on what happened in optometry during the week of January 13-January 17.

Previously, ClearVision Optical was Revo’s ECP channel distributor for 8 years.

Focused inSights 2024: Frame Buyers found that 78% of providers display between 200 and 1200 frames on their boards, with 70% of providers updating their inventory quarterly.

The award program includes Transitions Healthy Sight Ambassador, Eyecare Practice of the Year, Retailer of the Year, and Channel Partner of the Year awards.

WAVE Eye Care was developed by EyePrint Prosthetics, Advanced Vision Technologies (AVT), and WAVE Contact Lens System.

The guideline, titled "Care of the Patient with Primary Open-Angle Glaucoma," was developed by the AOA Evidence-based Optometry Guideline Development Group.

The company's lead product candidate Duravyu (vorolanib intravitreal insert), f/k/a EYP-1901, is anticipating topline data from several clinical trials in 2026.

The company will prioritize its cash in funding its ongoing Phase 1/2 PRISM clinical trial and Phase 3 4FRONT program.

The webinar will overview new offerings, details about the show’s updated brand and new exhibit hall layout, special events, and announcements regarding this year’s keynote speaker and other main stage sessions.

The new standards touch on alignment, terminology, expectations, and adherence, according to the council.

Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.

Catch up on what happened in optometry during the week of January 6-January 10.

The educational resources is now being used in 64% of the world's countries, with the US, the United Kingdom, Malaysia, India, Australia, and Canada as the most frequent users.

The module provides eye care professionals access to advanced thickness mapping and data insights for evaluating epithelial and stromal structures.

A recent study evaluated both deep neural networks and aggregation functions to determine ways to improve schizophrenia detection.

The 3-arm, multicenter, randomized, double masked, safety and efficacy study successfully met pre-specified visual acuity primary endpoints with statistically significant near vision improvements recorded at all time points over 8 hours.

EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.

Catch up on what happened in optometry during the week of December 30-January 3.

Model simulations conducted in part to assess net monetary benefit found that comprehensive eye examinations every 3 years were more cost effective than less frequent examinations.

From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.